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When killer lymphocytes recognize infected cells,
perforin delivers cytotoxic proteases (granzymes)
into the target cell to trigger apoptosis. What hap-
pens to intracellular bacteria during this process is
unclear. Human, but not rodent, cytotoxic granules
also contain granulysin, an antimicrobial peptide.
Here, we show that granulysin delivers granzymes
into bacteria to kill diverse bacterial strains. In
Escherichia coli, granzymes cleave electron trans-
port chain complex I and oxidative stress defense
proteins, generating reactive oxygen species (ROS)
that rapidly kill bacteria. ROS scavengers and bac-
terial antioxidant protein overexpression inhibit
bacterial death. Bacteria overexpressing a GzmB-
uncleavable mutant of the complex I subunit nuoF
or strains that lack complex I still die, but more
slowly, suggesting that granzymes disrupt multiple
vital bacterial pathways. Mice expressing transgenic
granulysin are better able to clear Listeria monocyto-
genes. Thus killer cells play an unexpected role in
bacterial defense.
INTRODUCTION
Immune killer cells help control intracellular bacteria, such as
listeria andmycobacteria, that evade other immunemechanisms
by replicating within phagocytes. When killer cells recognize
infected cells, they release their cytotoxic granule contents into
the immune synapse formed with the target cell to induce
apoptosis (Chowdhury and Lieberman, 2008). Host cell
apoptosis is triggered by the cytotoxic granule serine proteases
(granzymes [Gzm]), delivered into the target cell by the pore
forming protein, perforin (PFN). The Gzms are not known to
play any direct role in eliminating intracellular bacterial patho-gens. There are five human Gzms that independently activate
programmed host cell death, but GzmA and GzmB are the
most abundant. GzmB activates the caspase pathway, while
GzmA activates caspase-independent programmed cell death.
Cytotoxic granules of humans and some other mammals, but
not rodents, also contain a saposin-like pore-forming protein,
granulysin (GNLY), which preferentially disrupts cholesterol-
poor bacterial, fungal and parasite membranes (Krensky and
Clayberger, 2009; Stenger et al., 1998). Incubation of extracel-
lular bacteria, including mycobacteria, with GNLY is cytolytic,
but only using micromolar GNLY concentrations or extremely
hypotonic or acidic buffers (Ernst et al., 2000; Stenger et al.,
1998), suggesting that GNLY acts mostly against bacteria within
acidic phagosomes or may act with other agents. GNLY and the
Gzms, especially GzmB, are induced when T cells are incubated
with bacteria (Walch et al., 2009). Patients with T cell immunode-
ficiency have increased susceptibility to bacterial, fungal, and
parasitic infections. These findings suggest that human T cells
might control bacteria in unanticipated ways.
Mitochondria evolved from ancient bacterial symbionts within
eukaryotic cells (Gray, 2012). In eukaryotic cells targeted for
immune elimination, Gzms enter mitochondria where they cleave
proteins in electron transport chain (ETC) complex I to generate
superoxide anion, which plays a critical role in inducing
apoptosis (Martinvalet et al., 2008). In fact, superoxide scaven-
gers completely block cytolysis by killer lymphocytes (Martin-
valet et al., 2005). The core proteins of electron transport in
mammals derive from bacteria. Here, we show that GNLY de-
livers Gzms into bacteria to trigger rapid bacterial death. In aer-
obic Escherichia coli, as in mammalian cells, Gzms A and B
cleave subunits of ETC complex I, generating superoxide anion.
At the same time the Gzms cleave bacterial superoxide dismu-
tases and catalases, enzymes that inactivate superoxide anion
and peroxide, thus enhancing bacterial vulnerability to oxidative
damage and promoting bacterial death. E. coli lacking ETC I or
expressing a Gzm-resistant mutant of the key complex I sub-
strate (NuoF) are still killed, but more slowly. Intracellular Listeria
monocytogenes (Lm) are killed independently of the caspasesCell 157, 1309–1323, June 5, 2014 ª2014 Elsevier Inc. 1309
and before the host cell in a process that depends on a Gzm,
GNLY, and PFN.Mice carrying aGNLY transgene (Tg) expressed
only in killer lymphocytes (Huang et al., 2007) are more resistant
to Lm infection than wild-type (WT) mice. The protective effect of
GNLY is lost in Prf1/ mice. Thus the Gzms, GNLY, and PFN
together kill intracellular bacteria.
RESULTS
Gzms and Sublytic GNLY Induce Rapid Bacterial Death
Gram E. coli and gram+ Lm or Staphylococcus aureus were
treated with GzmA or B ± a sublytic concentration of GNLY
(100–400 nM, depending on the preparation) that lyses <20%
of bacteria (Figure S1 available online). Bacterial viability was
assessed by colony-forming assay (Figures 1A and 1B) and op-
tical density (OD) measurement of bacterial growth (Figures 1C
and 1D). Bacterial death was assessed by bacterial LIVE/DEAD
assay, which measures membrane integrity by relative uptake
of Syto-9, which enters both live and dead cells, and propidium
iodide (PI), taken up only by dead cells (Figures 1E–1G). Bacterial
viability and membrane integrity were significantly reduced by
just 5 min exposure to sublytic GNLY and either Gzm, but were
not killed by proteolytically inactive Ser-Ala (S-A) Gzm (Figures
1A and 1B). Gzm/GNLY treatment shifted growth curves to the
right by 200–400 min (Figure 1C). Given the bacterial doubling
time of 30 min, these results suggest that >95% of bacteria
were killed. To compare growth curves, the ratio of the time for
untreated versus treated bacteria to grow to an OD of 0.05
was defined as the relative threshold time (Tthreshold [untreated/
treated]) (Figure 1D). Because colony formation, growth curve
quantitation, and the cell death assay consistently gave compa-
rable results, they were used interchangeably in this paper.
Sublytic GNLY Delivers Gzms into Bacteria
Because GNLY permeabilizes bacterial cell membranes (Ernst
et al., 2000), we hypothesized that GNLY might deliver Gzms
into bacteria. Confocal microscopy (Figures 2A–2D; Movies
S1, S2, S3, S4, S5, and S6) of E. coli treated with fluorescently
labeled (AlexaFluor [AF]-488) Gzms with and without GNLY
showed that Gzms were internalized into bacteria in a GNLY-
dependent manner. In bacteria treated with AF-488 GzmB and
AF-647 GNLY, GzmB entered bacteria, while GNLY stayed on
the surface (Figure 2B). GzmB internalization was quantified (Fig-
ure 2D) by counting the number of cells clearly showing intracel-
lular fluorescence, assessing at least 300 bacteria per condition.
GzmB uptake was confirmed by flow cytometry (Figure 2E). Thus
GNLY delivered Gzms into bacteria.
Intracellular Lm Are Killed in a Gzm, GNLY, and PFN-
Dependent Process
To test GzmB activity against intracellular bacteria, Lm-infected
HeLa cells were treated with combinations of GzmB, PFN, and
GNLY (Figure 3A). After 1 hr, we measured host cell death by an-
nexin V and PI staining and viable Lm colonies (CFU) from hypo-
tonically lysed cells. Host cell killing required both GzmB and
PFN and was not enhanced by GNLY. PFN and GzmB without
GNLY did not significantly affect Lm viability, suggesting that
host cell death does not kill intracellular bacteria. Fewer bacterial1310 Cell 157, 1309–1323, June 5, 2014 ª2014 Elsevier Inc.colonies grew in cells treated with GNLY and either PFN or
GzmB. However, bacterial viability was most reduced when all
three effector molecules were applied. We repeated this exper-
iment using HeLa cells stably overexpressing BCL2, which in-
hibits GzmB-mediated apoptosis. BCL2 overexpression
rescued host cells, but did not affect Lm CFUs (Figure S2A).
Host cells were killed independently of GNLY, but required
both PFN and GzmB, while efficient bacterial elimination
required all three enzymes. This result is consistent with a previ-
ous report showing that host cell apoptosis is neither sufficient
nor necessary for CD8+ CTL to kill intracellular Mycobacterium
tuberculosis (Thoma-Uszynski et al., 2000).
A human Lm-specific CD8 T cell line was used to test whether
CTLs destroy intracellular Lm in infectedmonocyte-derived den-
dritic cells (MDDC). Incubation of infected MDDC for 2 hr with
increasing numbers of killer cells reduced both host cell and
Lm viability compared to cultures without CTLs (Figure 3B).
Bacteria were killed at lower effector:target cell (E:T) ratios
than host cells. Bacterial viability was significantly reduced after
30 min, but host cell death, measured by 51Cr release, did not
become significant until 90 min after adding killer cells (Fig-
ure 3C). Thus intracellular Lm killing was more efficient and rapid
than host cell killing. Rapid bacterial destruction before host cell
lysis could reduce pathogen spreading from dying cells. Cas-
pase inhibition reduced host cell death, but bacterial death
was unaffected, confirming the independence of bacterial and
host cell death (Figure 3B). Both deaths were completely in-
hibited by the Gzm inhibitor, 3,4-dichloroisocoumarin (DCI) (Fig-
ure 3B). Thus bacterial death requires active Gzms and does not
depend on activated caspases or host cell death.
To assess the importance of GNLY in bacterial elimination by
mouse killer lymphocytes, we compared splenocytes from
GNLY-transgenic (Tg, GNLY/+) and wild-type (WT) BALB/c
mice (Huang et al., 2007). The Tg was only expressed in CTL
and natural killer (NK) cells, like the endogenous human protein
(Figure S2B). In the spleens of naive GNLY-Tg mice, GNLY
was expressed by approximately one-third of NKp46+ NK cells,
but was not expressed by T or B cells or myeloid cells. After
5 days of in vitro IL-2, approximately two-thirds of NK cells and
a third of CD8 T cells, but only 7% of CD4 T cells, from GNLY-
Tg mice expressed GNLY (Figures 3D and S2C). GzmB ex-
pression was comparable in WT and GNLY-Tg mice. After
in vitro culture in IL-15, GNLY was only expressed in NK cells
and CD62LCD44+ effector and effector memory CD8 T cells
from Tg mice (Figure S2C).
To assess the role of Gzms and PFN in GNLY-mediated
bacterial killing,GNLY-Tgmice were backcrossed withGzmb/
and Prf1/ BALB/c mice. Splenocytes from each strain, har-
vested 8 days after Lm infection, were incubated with anti-
CD3-coated Lm-infected RAW264.7 cells (Figure 3E). WT and
Gzmb/ splenocytes killed host cells and Lm equivalently,
probably because the lack of GzmB is well compensated by
other Gzms (Chowdhury and Lieberman, 2008). PFN-deficient
splenocytes, even if they expressed GNLY, did not kill host cells
or intracellular bacteria. The GNLY-Tg had no significant effect
on host cell killing, but significantly reduced bacterial survival.
PFN-sufficient killer cells reduced Lm CFUs even in the absence
of the Tg, presumably because a dying cell is not a hospitable
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Figure 1. Gzms and Sublytic GNLY Induce Rapid Bacterial Death
(A–D) E. coli, Lm and S. aureus were treated with Gzms in indicated concentrations and sublytic GNLY for 20 min or indicated times before samples were
harvested and bacterial viability was assessed by CFU assay (A and B), or by monitoring bacterial growth curves by optical density (C and D). For growth curves,
the time to reach OD600 0.05 was defined as Tthreshold (E). (S-A) refers to the Ser-Ala active site mutant inactive Gzm. In (A), S. aureus was tested only for GzmB
susceptibility.
(E–G) Bacterial viability was assessed by LIVE/DEAD assay after incubation with sublytic GNLY and GzmB in the indicated concentrations and times. Syto-9
enters live and dead bacteria, while PI only enters dead bacteria. (E) shows representative staining of E. coli treated as indicated for 20 min and (F) is the
quantification of live cells relative to untreated bacteria. (G) Shows a representative time course.
Bar graphs show the mean ± SEM of at least three independent experiments; in other panels representative data from at least three experiments are shown.
Statistical differences compared to untreated control samples were calculated using unpaired Student’s t test. *p < 0.05.
See also Figure S1.
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host. Thus, rapid, efficient bacterial death requires both GNLY
and PFN.
GNLY-Tg Mice Clear Lm More Effectively than WT Mice
To examine the in vivo significance of GNLY-mediated destruc-
tion of intracellular bacteria, we assessed the effect of theGNLY-
Tg in WT, Gzmb/ and Prf1/ backgrounds on clearance of
intraperitoneally injected Lm (0.2 LD50) (Figure 3F). GNLY-Tg
mice that expressed PFN more effectively cleared Lm. Bacterial
counts in the liver and spleen 3 days later were reduced by 3
logs in GNLY-Tg WT and Gzmb/ mice. As expected (Ka¨gi
et al., 1994), PFN-deficient mice had significantly more Lm in
the spleen and a trend toward increased bacteria in the liver
than WT and Gzmb/mice, and the GNLY-Tg provided no pro-
tection. Thus GNLY antibacterial activity in naive mice requires
PFN, implicating the granule exocytosis pathway of innate cyto-
toxic effector cells in antibacterial immune defense. The more
efficient clearance by GNLY-Tg naive mice was likely due to
NK cells, because these are the only cells that express GNLY
in naive mice (Figure S2) (Huang et al., 2007).
While NK cells protect naive mice from Lm, CD8 T cells are the
mainstays of immune protection in previously exposed mice. To
assess the importance of GNLY in CD8 T cells in the recall
response, WT and GNLY-Tg mice in Prf1 WT or deficient back-
grounds were immunized with 0.2 LD50 Lm and 3 weeks later
challenged with 20 LD50 (Figure 3G). Two of eight
GNLY+/Prf1+/+ mice completely cleared Lm within 40 hr, while
all WT mice had detectable bacteria. Moreover, GNLY-Tg mice
that had detectable bacteria had on average 3 logs fewer bac-
teria thanWTmice. As in the primary response, theGNLY Tg pro-
vided no advantage in PFN-deficient mice, indicating that PFN is
needed for both NK cells and T cells to kill intracellular bacteria.
GNLY-Delivered Gzms Rapidly Induce ROS in Bacteria
An early event in Gzm-induced death of mammalian cells is ROS
induction (Martinvalet et al., 2008). Neutrophils and macro-
phages rely on ROS to kill phagocytosed bacteria (Hampton
et al., 1998). Bactericidal antibiotics may also elicit ROS to kill
bacteria efficiently, although this finding has been recently con-
tested (Kohanski et al., 2007; Keren et al., 2013; Liu and Imlay,
2013). A schematic of ROS pathways in bacteria is shown in Fig-
ure 4A. To assess whether GNLY-delivered GzmB induces ROS,
bacteria were labeled with the superoxide-sensitive fluorescent
reporter, dihydroethidium (DHE). GzmB treatment of E. coli,
Lm, and S. aureus generated ROS in a GNLY and dose-depen-
dent manner (Figure 4B). DHE staining showed both low and
high fluorescence intensity populations, the latter increasing
with Gzm concentration. (Because GNLY does not bind homo-
genously (Figure 2B), a lethal Gzm concentration may not accu-Figure 2. Sublytic GNLY Delivers Gzms into Bacteria
(A–C) E. coli treated with catalytically inactive, AF488-labeled GzmB (GzmB-488) ±
stained with FM4-64 and DAPI and visualized by confocal microscopy. High-reso
intensity for each color in (A) was measured along the indicated dashed lines. Sc
(D) Analysis of the percentage of bacteria in which GzmB clearly localized within ba
images are in Movies S1, S2, S3, S4, S5, and S6.
(E) E. coli, treated with inactive GzmB ± sublytic GNLY, were stained with anti-G
Experiments in (A–C) and (E) are representative of at least three independent expmulate in all cells at limiting Gzm concentrations, accounting for
the nonfluorescent population.) ROS induction was detected
within 5 min (Figure 4C). The superoxide-specific oxidation
product of DHE, 2-hydroxyethidium (emission peak, 580 nm)
can be distinguished from its nonspecific oxidation product,
ethidium (605 nm) after excitation at 488 nm (Zhao et al., 2003)
(Figures 4D and S3). H2O2 treatment generated only the ethidium
peak.WhenE. coliwere treatedwith GzmB/GNLY or the electron
transport chain (ETC) complex I inhibitor rotenone, which
induces superoxide, DHE-stained cells emitted at both wave-
lengths, suggesting that superoxide and other ROS were pro-
duced. To confirm H2O2 production, we measured its release
from the catalase/peroxidase null LC106 strain (Liu and Imlay,
2013) after treatment with GNLY/GzmB or the superoxide-
inducing poisons, rotenone or paraquat (Figure 4E). As ex-
pected, treatment with either the poisons or GNLY/GzmB, but
not GNLY or GzmB alone, significantly increased H2O2 produc-
tion, which was inhibited by the superoxide scavenger Tiron or
the H2O2 scavenger dimethylthiourea (DMTU). Complete in-
hibition by Tiron suggests that superoxide anion is the first
ROS species formed.
E. coli sense and combat oxidative stress by activating the
ROS sensors OxyR and SoxR, which preferentially sense H2O2
and superoxide, respectively, to trigger the rapid transcription
of oxidative stress response genes (Chiang and Schellhorn,
2012). OxyR induces catalase (katG), ferrochelatase (hemH),
and the regulatory RNA oxyS and represses oxyR itself in a nega-
tive feedback loop. SoxR oxidation induces transcription of
soxS, which then drives expression of genes that protect against
superoxide stress. Treatment of E. coli for 10 min with GzmB/
GNLY, H2O2, or rotenone-induced transcription of soxS, oxyS,
katG, and hemH, but not oxyR (Figure 4F). Tiron abolished the
transcriptional response to GNLY/GzmB and rotenone, but had
less of an effect on H2O2-treated cells, providing further evi-
dence that GzmB/GNLY, like rotenone, induce the bacterial
oxidative stress transcriptional program. recA-deficient strains,
impaired in DNA repair, are especially susceptible to ROS
(Konola et al., 2000). As expected, recA mutants were signifi-
cantly more susceptible to Gzm/GNLY killing (Figure 4G). These
data taken together indicate that superoxide and peroxide and
other downstream ROS are rapidly generated in bacteria treated
with GzmB and GNLY.
ROS Contribute to Rapid Bacterial Death Induced by the
Gzms
To assess whether superoxide anion and/or other ROS mediate
bacterial death by GzmB/GNLY, we examined the effect of
GNLY ± GzmB and the superoxide anion-inducers, rotenone
and paraquat, as controls, on growth of E. coli overexpressingsublytic unconjugated (A and C) or AF647-conjugated GNLY peptide (B), were
lution images (A and B) and representative fields are shown (C). Fluorescence
ale bars represent 1 mm (A and B) and 10 mm (C).
cteria based on counting 400–3,000 bacteria per condition. Representative 3D
zmB and analyzed by flow cytometry.
eriments.
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superoxide dismutase (sodA), which converts superoxide anion
to H2O2, or catalase (katG), which inactivates H2O2. Overexpres-
sion of either oxidative defense enzyme protected bacteria from
GzmB/GNLY (Figure 5A), suggesting that superoxide and its
downstream product H2O2 both contributed to the toxic effect
of GzmB and GNLY. As expected, overexpressing sodA pro-
tected against paraquat, but not H2O2, while katG provided
protection against H2O2 (Figure 5A). Rotenone and paraquat at
the concentrations used induced similar levels of H2O2 as
GzmB and GNLY (Figure 4E). However, although these strong
oxidants inhibited bacterial growth, because of effective antiox-
idant defenses, bacteria survived treatment with paraquat and
H2O2, as assessed by the LIVE/DEAD assay (Figure 5B). How-
ever, GzmB and GNLY not only caused growth arrest, but also
induced death. This death was largely rescued by sodA over-
expression, which also greatly reduced superoxide levels as
monitored by DHE fluorescence (Figure 5C), suggesting that
superoxide generation plays a critical role in initiating bacterial
death. Because bacteria are able to recover from strong oxida-
tive stresses that generate comparable levels of peroxide, but
die from Gzm and GNLY treatment, it is likely that GzmB does
more than generate ROS (see below).
Tiron and Mn(III)tetrakis(4-benzoic acid)porphyrin (MnTBAP),
which act as superoxide reducing agents (Ledenev et al., 1986)
or inhibit superoxide formation (Taiwo, 2008), completely
blocked rapid bacterial death (Figure 5D). Trolox, an a-tocoph-
erol derivative that scavenges free radicals, the hydrogen
peroxide scavenger DMTU and the iron-chelator deferoxamine
also reduced bacteria killing, but less than Tiron or MnTBAP,
providing further evidence that superoxide anion is the first
ROS species produced. Superoxide damages Fe-S cluster-con-
taining enzymes, such as aconitase (Gardner and Fridovich,
1991). To confirm that superoxide was generated by GNLY
and GzmB, we measured aconitase activity in treated E. coli.
GzmB and GNLY, but not GNLY on its own, rapidly reduced
aconitase activity to a similar extent as rotenone (Figure 5E).
Moreover, Tiron, which enhanced aconitase activity of untreated
bacteria, completely rescued aconitase activity after GzmB/Figure 3. Intracellular Lm Are Killed in a Gzm, GNLY, and PFN-Depend
(A) Lm-infected HeLa cells were treated with GzmB, PFN, and/or GNLY in indicate
viability by Annexin V-PI staining (lower). Mean ± SEM of three independent e
compared to untreated cells by unpaired Student’s t test.
(B and C) Lm-infected MDDC were incubated for 2 hr with human Lm-specific C
before assessing host cell viability by 51Cr-release and intracellular bacterial CFU
treated with zVAD-fmk or by using effector cells pretreated with the Gzm inhib
statistically significant differences (p < 0.05) compared to untreated cells by unp
(D and E) Splenocytes fromWT orGNLY-Tg BALB/c mice were stimulated with IL-
(D). Splenocytes from Lm-primed WT or GNLY-Tg mice in WT, Prf1/ or Gzm
indicated times at an E:T ratio of 3 with Lm-infected RAW264.7 cells coated with
assay (E, top) and host cell viability was measured in parallel by 51Cr-release. (E, b
significant p values calculated by unpaired Student’s t test between cells from W
(F) For the primary response, WT, GNLY-Tg, Prf1/, Prf1/GNLY-Tg, GzmB/
bacterial counts in the spleen and liver were measured 72 hr later.
(G) For the recall response, WT, GNLY-Tg, Prf1/, and Prf1/GNLY-Tg BALB/c
with 20 LD50. Bacterial counts in the spleen and liver were measured 40 hr later. B
detection limit.
Statistical differences compared to WT mice or between WT and GNLY-Tg m
significant p values are shown.
See also Figure S2.GNLY or rotenone treatment. Thus superoxide anion initiates
bacterial death that is executed in part by downstream ROS.
Gzm Cleavage of Bacterial Complex I Subunits Causes
Oxidative Damage
GzmA and GzmB generate ROS in mammalian cells by cleaving
ETC complex I (Martinvalet et al., 2008; Guillaume Jacquemin,
Daniela Margiotta, Atsuko Kasahara, Esen Yonca Bassoy,
M.W., J.T., J.L. and D.M, unpublished data). The core compo-
nents of electron transport are conserved between bacteria
and mammals. Bacterial complex I (a simpler enzyme of 13 or
14 subunits in bacteria versus 45 in mammals) (Efremov et al.,
2010; Spehr et al., 1999) is an L-shaped complex with one arm
embedded in the membrane (NADH-ubiquinone-oxidoreduc-
tase [Nuo] subunits A, H, J–N), connected by a cytosolic stalk
(subunits B, CD, I) to the catalytic core (subunits E, F, G; see Fig-
ure 7C) (Efremov et al., 2010). Incubation of purified E. coli com-
plex I with nM concentrations of GzmA or GzmB for 10 min led to
cleavage of several Nuo subunits, as visualized by Coomassie
blue staining (Figure 6A). NuoF, the homolog of mammalian
NDUFV1, which binds NADH to initiate electron transport (Frie-
drich and Weiss, 1997), was the best substrate. Bands for
NuoG, NuoCD (both in the catalytic domain) (Efremov et al.,
2010), and possibly NuoL and NuoM also were reduced in inten-
sity at the highest concentration (200 nM). GzmA (70 nM) cleaved
NuoF and NuoG comparably, generating an 80 kDa NuoG
cleavage product. To verify their cleavage, because no anti-
bodies were available, the NuoG, NuoCD, NuoF, and NuoM
candidate substrates were expressed as N-terminal GST-fusion
proteins in E. coli and purified for in vitro Gzm cleavage assays
(Figure S4A) or tested for cleavage in intact bacteria (Figures
6B and 6C). NuoCD, F, and G were in vitro substrates of both
GzmA and GzmB with detectable cleavage products, which
were analyzed by mass spectrometry to determine their cleav-
age sites. NuoM was not a substrate. Thus the Gzms target
the more accessible, catalytic components of complex I.
GzmB cleaved NuoCD at D146, NuoF at D20, D27, and D48
and NuoG at D824. Although GzmA cleaved all three proteins,ent Process
d concentrations and analyzed 1 hr later for bacterial CFU (upper) and host cell
xperiments. Asterisks indicate statistically significant differences (p < 0.05)
TLs at indicated E:T ratios in (B) or at an E:T ratio of 3 for indicated times in (C)
. (B) Experiments were performed in the absence of inhibitors or in target cells
itor DCI. Mean ± SEM of three independent experiments. Asterisks indicate
aired Student’s t test.
2 in vitro for 5 days before evaluating GNLY and GzmB levels by flow cytometry
b/ backgrounds were isolated 8 days postinfection and then cultured for
anti-CD3. Viable bacteria in hypotonically lysed cells were assessed by CFU
ottom). (E) Shows mean ± SEM of three independent experiments. Statistically
T and GNLY-Tg mice in each background are shown.
, and GzmB/GNLY-Tg BALB/c mice were infected i.p. with 0.2 LD50 Lm, and
mice were immunized i.p. with 0.2 LD50 Lm and 3 weeks later challenged i.p.
lack bars showmean log-transformed colony counts. Dashed lines indicate the
ice in each background were calculated using the Wilcoxon rank-sum test;
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only the cleavage site of NuoCD was mapped (R228). These
cleavage sites are consistent with the substrate specificity of
GzmB for aspartic acid and the tryptase activity of GzmA. In
bacteria expressing the fusion proteins, GzmB and GNLY treat-
ment generated cleavage products of the three substrates, but
not NuoM, detected by GST immunoblot, confirming that they
are substrates in intact bacteria (Figure 6B). Four unrelated con-
trol E. coli proteins (XerC, MinC, NlpL, MotB), expressed as GST
fusion-proteins, were not cleaved in GNLY and GzmB-treated
E. coli (Figure S4B). The NuoCD cleavage fragment was de-
tected within 5 min of GzmB treatment (Figure 6C), consistent
with the timing of ROS production and bacterial death. Thusmul-
tiple cytosolic subunits of complex I are specific Gzm substrates
in E. coli.
To determine whether NuoF cleavage contributes to ROS
generation and bacterial death, a GzmB-uncleavable mutant of
E. coli NuoF was generated by mutating the three cleavage
site Asps to Ala (Figure S4C). GzmB and GNLY did not cleave
triple mutant NuoF in bacteria, but GzmA cleavage was unaf-
fected. ROS and death induced by GzmB andGNLY were signif-
icantly reduced and delayed in bacteria expressing triple mutant,
compared to wild-type (WT), NuoF (Figure 6D and 6E). The
mutation did not inhibit the effectiveness of GzmA. The impor-
tance of targeting complex I was also assessed using the
E. coli strain, ANN0221/pBADnuo/His-nuoF (Figures 6F, S4D
and S4E), in which an L-arabinose-sensitive promoter controls
the nuo operon. These bacteria express His-tagged NuoF (Spehr
et al., 1999), only when L-arabinose is in the medium (Fig-
ure S4D). Lack of complex I completely protected GzmB and
GNLY-treated bacteria from ROS induction and rapid death,
measured after 15 min. However, after 1 hr, viability of complex
I-deficient bacteria was significantly reduced, although ROS
measured by DHE fluorescence only increased slightly. Thus
GzmB kills bacteria independently of complex I, although with
delayed kinetics. To confirm that ETC complex I is the source
of superoxide, we compared superoxide/peroxide generation
by GzmB-treatedmembranes prepared from arabinose-induced
or uninduced ANN0221/pBADnuo/His-nuoF bacteria by
measuring NADH oxidation and cytochrome c reduction (Fig-
ure S4D). Complex I sufficient membranes generated superox-
ide in response to GzmB and rotenone, but deficient membranesFigure 4. Gzms Rapidly Induce ROS in Bacteria
(A) Schematic of ROS production and metabolism in E. coli. ROS scavengers (b
(B) Bacteria treated for 20 min with GzmB in indicated mM concentrations ± sublyt
(DHE), and assayed by flow cytometry. Representative data from three independ
(C) Time course of DHE staining after treatment with sublytic GNLY and 200 nM
(D) E. coli were treated with 150 nM GzmB + sublytic GNLY, GNLY only, rotenon
scanning fluorescent emission spectra (excitation at 488 nm).
(E) Catalase/peroxidase null E. coli strain LC106was treated for 15min with 200 nM
presence or absence of Tiron or DMTU before the reaction was diluted in PBS co
by the increase in Amplex Red fluorescence. Mean ± SEM of three independent e
untreated cells, calculated by unpaired Student’s t test, are indicated by asterisk
(F) Oxidative stress-regulated RNAs were analyzed by quantitative RT-PCR in E.
(40 mM) in the presence or absence of 10 mM Tiron. Mean ± SEM of five indep
compared to corresponding samples without Tiron, were calculated by unpaired
(G) recA-deficient E. coli or the parental strain (ML1655) were treated with indica
bacterial growth. The time to reach OD600 0.05 was defined as Tthreshold. Mean
compared to WT bacteria, calculated using unpaired Student’s t test, are indica
See also Figure S3.did not. We compared the rate of NADH oxidation with the rate
of cytochrome c reduction in GzmB-treated and untreated
membranes to estimate what proportion of electrons were
channeled into superoxide production. In GzmB-treated
membranes10%of electrons were channeled into superoxide,
compared to only 1% of electrons in untreated membranes.
Addition of SOD to the reaction decreased cytochrome c reduc-
tion to background, confirming that superoxide anion was
responsible (Figure S4E).
Complex I is poorly characterized in Lm. A BLAST search iden-
tified propanediol utilization protein, subunit S (PduS) as the best
match for E. coli NuoF. Lm pduS contains the N-terminal NADH:
ubiquinone oxidoreductase catalytic site sequence of mamma-
lian NDUFV1, the key residues responsible for flavin mononucle-
otide binding and conserved cysteines that participate in the N3
Fe-S cluster. PduS was also a GzmB target, both in vitro and in
Lm expressing the tagged protein (data not shown). Thus the
Gzms may target oxidoreductases in diverse bacterial strains.
GzmB Destroys ROS Degrading Enzymes in E. coli
The level of cellular ROS reflects the balance between ROS
generation and elimination by cellular antioxidant defenses.
Because GzmB/GNLYmore effectively killed bacteria than para-
quat (Figure 5B), we suspected that GzmBmight also cleave and
disable proteins that protect bacteria from oxidative damage.
Indeed SodA and KatG GST fusion proteins were cleaved within
20 min in bacteria treated with GzmB/GNLY, but not GNLY on its
own (Figure 7A). Furthermore, in vitro treatment of these purified
enzymes with 150 nM GzmB decreased their catalytic activity
(Figure 7B). Preliminary proteomics analysis suggests that
GzmB cripples oxidative stress defense by cleaving all three
Sods (A, B, and C) and the major peroxide inactivating enzymes
KatG, KatE, and AhpC in E. coli (Seaver and Imlay, 2001). Thus,
ROS accumulates in GNLY/GzmB-treated bacteria not only
because superoxide is induced, but also because bacteria are
less able to inactivate it.
DISCUSSION
We propose amodel in which first PFN delivers Gzms and GNLY
into infected cells targeted for immune elimination and thenlue) and superoxide inducing poisons (green) act at the indicated sites.
ic GNLY were stained with the fluorescent superoxide reporter, dihyroethidium
ent experiments.
GzmB. Representative data from three independent experiments.
e, H2O2, or left untreated for 10 min and stained with DHE or ethidium before
GzmB ± sublytic GNLY, rotenone (rot, 20 mM), or paraquat (PQ, 200 mM) in the
ntaining Amplex Red/horseradish peroxidase. H2O2 production was measured
xperiments is shown. Statistically significant differences (p < 0.05) compared to
s.
coli treated for 10 min with 150 nM GzmB ± GNLY, rotenone (10 mM), or H2O2
endent experiments is shown. Statistically significant differences (p < 0.05),
Student’s t test and are indicated by asterisks.
ted concentrations of GzmB ± GNLY for 15 min and viability was assessed by
± SEM of three independent experiments is shown. Significant differences
ted by asterisks. *p < 0.05.
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Figure 5. ROS Contribute to Rapid Bacterial Death Induced by the Granzymes
(A) E. coli overexpressing SodA, KatG, or GST were treated for 15 min with 150 nM GzmB ± GNLY, rotenone (Rot, 10 mM), paraquat (PQ, 100 mM), or H2O2
(200 mM) and analyzed for bacterial growth. Graphs show the mean ± SEM of at least three independent experiments.
(B) E. coli overexpressing sodA or GST as control were treated with 150 nM GzmB ± sublytic GNLY, GNLY only, paraquat (PQ, 500 mM), or hydrogen peroxide
(H2O2, 500 mM) for 15 min and analyzed by LIVE/DEAD assay. Graphs show the mean ± SEM of at least three independent experiments.
(C) E. coli overexpressing superoxide dismutase (SodA), catalase (KatG), or empty vector (GST) were treated with 150 nMGzmB + sublytic GNLY or left untreated
for 10 min and stained with DHE before scanning the fluorescent emission spectra after excitation at 488 nm. Solid lines indicate GNLY/GzmB-treated bacteria;
dashed lines are control untreated bacteria.
(D) E. coli were incubated with ROS scavengers MnTBAP, Tiron, Trolox, Dimethylthiourea (DMTU), or the iron-chelator, deferoxamine, and treated with 150 nM
GzmB ± GNLY for 15 min before assessing bacterial growth. The sites of action of SOD, catalase, and the chemical ROS scavengers are shown in Figure 4A.
Graphs show the mean ± SEM of at least three independent experiments. Statistical differences, calculated relative to GST control or untreated samples using
unpaired Student’s t test, are indicated by asterisks. *p < 0.05.
(E) E. coli treated with 400 nM GzmB and sublytic GNLY or 2.5 mM rotenone in the absence or presence of 20 mM Tiron for indicated times were lysed and
aconitase activity in the cleared bacteria lysates was measured. Data were normalized to untreated bacteria in the absence of Tiron. Graphs show the mean ±
SEM of three independent experiments. Significant differences compared to untreated control samples, calculated using unpaired Student’s t test, are indicated
by asterisks. *p < 0.05.GNLY introduces Gzms into bacteria (Figure 7C). In the bacterial
cytosol, Gzms proteolytically attack ETC complex I. Aerobic
bacteria have powerful antioxidant responses, which enable
them to withstand basal ROS generated in an aerobic environ-
ment and exposure to potent oxidants, such as paraquat and
peroxide (Figure 5B). However, the Gzms also cleave and inacti-
vate the cornerstone enzymes of oxidative defense, the Sods
and catalases. By crippling the oxidative stress response, the
Gzms inflict irreparable damage.
Gzms and caspases induce apoptosis in mammalian cells by
triggering programs targeting critical processes needed for sur-
vival—causing DNA damage, inducing ROS, disrupting themito-
chondrial outer membrane, interfering with RNA splicing and
protein translation. No one substrate/pathway is universally1318 Cell 157, 1309–1323, June 5, 2014 ª2014 Elsevier Inc.essential for death. For example, mitochondrial damage is
needed in some death pathways to kill some cells, but not
others. DNA damage is not essential, because enucleated cells
also undergo programmed cell death. Apoptosis also disrupts
cellular repair (e.g., by cleaving and inactivating key DNA repair
enzymes). This multipronged attack means that virus-infected
or cancer cells that resist damage to one pathway or another
are still killed. The Gzms or caspases typically cleave a few
hundred substrates in mammalian cells. Our data suggest that
Gzm-mediated bacterial cell death is also a complex program
of damage that disrupts key pathways and interferes with repair,
providing a mechanism to kill diverse bacterial strains growing
under varied conditions. A case in point is the death of bacteria
lacking complex I, which suggests that both aerobic and
(legend on next page)
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anaerobic bacteria will be killed. Preliminary proteomics analysis
of GzmB-treated E. coli and Lm (data not shown) suggests that
the Gzms cleave 100–200 proteins in each species, many of
which are functional homologs. GzmB is not indiscriminate in
its targets. More than 90% of proteins are not substrates, and
the candidate substrates are concentrated in pathways involved
in aerobic and anaerobic metabolism, DNA repair, protein syn-
thesis, and stress responses. Cleavage of other substrates will
likely enhance the cytotoxic effect of Gzms against aerobes
and lead to slower killing of anaerobes, broadening the impact
of this immune defense mechanism. The implication is that it
will be difficult for bacteria to evade or develop resistance to killer
cell-mediated death. However, these putative additional sub-
strates require careful experimental validation, and the effect of
the Gzms on anaerobic bacteria and other bacterial strains re-
quires further study.
Attack of complex I is a shared critical feature of programmed
cell death in bacteria and mammalian cells (Martinvalet et al.,
2008; Ricci et al., 2004). Superoxide scavengers protect against
death in both systems. Cleavage of catalytic domains of
complex I, which protrude into the cytosol of bacteria or the
mitochondrial matrix of mammalian cells, disrupts the flow of
electrons. In bacteria the dominant GzmA and B substrate
NuoF, which binds NADH and FMN, initiates electron transport.
Cleavage of NuoF at its N-terminal Asp residues D20, D27, and
D48 by GzmB is not expected to disrupt electron capture at
the NADH binding site (E95). We propose that electrons
captured from NADH by complex I that are normally transferred
to ubiquinone get sidetracked to react with dissolved oxygen
to generate superoxide anion. Superoxide is not ordinarily
cytotoxic for bacteria. Based on our experiments with ROS scav-
engers, catalase overexpression, and measurement of H2O2
production, we propose that superoxide anion is rapidly con-
verted to more cytotoxic intermediates, including peroxide.
Moreover, proteolysis of SodA and KatG (and probably other
oxidative repair enzymes) cripples bacterial handling of ROS to
guarantee bacterial death. It will be worthwhile to examine
whether the Gzms or caspases also cleavemammalian oxidative
defense enzymes, which has not been studied.
Although we mostly focused on GzmB, preliminary data sug-
gest that GzmA, as well as GzmM, an important Gzm in NK cells,Figure 6. Gzms Cleave Complex I Subunits to Cause Oxidative Damag
(A) Purified E. coli complex I was treated with GzmA (or its inactive mutant [S
Coomassie staining. The NADH:ubiquinone oxidoreductase (Nuo) subdomains
cleavage fragment.
(B) E. coli expressing GST-tagged NuoCD, NuoF, NuoG, or NuoM were treated
*Indicates cleavage fragments.
(C) The kinetics of NuoCD cleavage in E. coli.
(D) E. coli overexpressing wild-type (WT) or GzmB-uncleavable mutant (MUT) Nuo
by flow cytometry (left) or bacterial viability by CFU assay (right).
(E) E. coli overexpressingWT or MUT NuoF were treated with GNLY and GzmB or
by CFU assay (middle) or growth curves (right; solid lines, bacteria expressing W
differences (p < 0.05) between WT and MUT strains are indicated.
(F) E. coli strain ANN0221/pBADnuo/His-nuoF expressing inducible complex I w
GzmB for 15 or 60 min. ROS production was measured by DHE staining and flow
(right).
Representative flow cytometry histograms and growth curves andmean ± SEM of
0.05) between indicated groups, calculated using unpaired Student’s t test, are i
See also Figure S4.
1320 Cell 157, 1309–1323, June 5, 2014 ª2014 Elsevier Inc.also attack bacterial complex I. Myeloid cell serine proteases are
also implicated in antibacterial defense. Mice deficient in neutro-
phil elastase or cathepsin G, which are closely related to the
Gzms, are more susceptible to bacterial infection (Hirche et al.,
2008; Steinwede et al., 2012). Neutrophils and other cells also
express antimicrobial peptides with properties similar to GNLY
(Gallo and Nizet, 2003). Other leukocyte serine proteases and
antimicrobial peptides might substitute for Gzms and GNLY in
bacterial defense.
Future experiments in GNLY-Tg mice should investigate
whether Gzms and GNLY protect in vivo against extracellular
bacteria. Gzm concentrations in extracellular fluids during bac-
terial infection are unknown. Extracellular Gzms are elevated
during viral infection and inflammation (such as in rheumatoid
arthritic joints, in bronchoalveolar fluid of asthma patients, or in
the blood during acute CMV or chronic HIV infection) (Spaeny-
Dekking et al., 1998). GNLY has been measured in the plasma
of healthy and tuberculosis-infected people (Pitabut et al.,
2011). Gzm and GNLY concentrations in these settings were at
most in the low-nanomolar range, below the concentrations we
needed to kill extracellular bacteria in vitro. However, local con-
centrations may be higher at the site of infection, depending on
the density and activation of infiltrating cytotoxic immune cells.
Heretofore, the main anti-infective function of killer lympho-
cytes in infection was thought to be antiviral. This study shows
that NK cells and CTLs also protect us against intracellular bac-
teria by a novel mechanism that deploys all three classes of
effector molecules, Gzms, GNLY, and PFN. GNLY is active
against cholesterol-poor membranes, found in bacteria, fungi,
and parasites, and the core components of electron transport
are conserved among species. Thus the Gzm-PFN-GNLY trio
may well act on other intracellular pathogens, including fungi
and parasites. This merits further study.EXPERIMENTAL PROCEDURES
Treatment of Bacteria with Cytotoxic Proteins
Gzms ± sublytic GNLY were incubated at 37C with 105/ml exponential phase
bacteria in 20 ml of 10 mM NaCl, 20 mM Tris (pH 7.4). A sublytic concentration
of GNLY was chosen to cause <20% death by CFU assay. Treated bacteria
were diluted in lysogeny broth (LB) and plated on LB (E. coli, S. aureus) or braine
-A]) or GzmB in indicated concentrations for 10 min before SDS-PAGE and
corresponding to each visible band are labeled. *Indicates a NuoG GzmA
with sublytic GNLY and/or GzmB for 20 min. GST immunoblots are shown.
F were treatedwith GNLY andGzmB for indicated times beforemeasuring ROS
GzmA for 10 min before assessing ROS by DHE fluorescence (left) and viability
T NuoF; dashed lines, bacteria expressing MUT NuoF). Statistically significant
as induced or not for 60 min with L-arabinose before treatment with GNLY ±
cytometry (left) and bacterial viability was assessed by bacterial growth curves
at least three independent experiments are shown. Significant differences (p <
ndicated by asterisks.
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Figure 7. Granzyme Destroys ROS Degrading Enzymes and Model of GNLY/GzmB Induced Bacterial Death
(A) E. coli expressing GST-SOD (SodA), GST-catalase (KatG), or empty vector (GST) were treated with GzmB and sublytic GNLY for 20 min. Cleavage was
assessed by GST immunoblot. Cleavage products are indicated by asterisks.
(B) PurifiedGST-SodA (20 nM, left) or GST-KatG (1 mM, right) were pretreated for 20minwith indicated concentrations of GzmB before assessing enzyme activity.
SOD activity was assessed bymeasuring cytochrome c reduction. Catalase activity relative to GzmB-untreated sampleswas assessed by oxidation of phenol red
in the presence of horseradish peroxidase. Representative curves (left) or mean ± SEM of three independent measurements (right) are shown. Significant
differences compared to untreated control samples, calculated using unpaired Student’s t test, are indicated by asterisks. *p < 0.05.
(C) Model for GzmB/GNLY action on bacteria. GNLY permeabilizes bacterial membranes to allow Gzms to enter the bacterial cytosol, where they attack catalytic
subunits of ETC complex I. Cleavage of ETC complex I interferes with transport of electrons, which leak into the cytosol to reduce oxygen to superoxide. Sod and
catalase are also cleaved to prevent detoxification of superoxide anion. Increased ROS lead to membrane, protein and DNA damage. Cleavage of other bacterial
proteins also contributes to bacterial death.heart infusion (BHI) (Lm) agar plates to determine CFU, which were normalized
to CFU in control conditions.
Imaging GzmB Delivery
E. coli, treated with 500 nM AF488-labeled Gzm ± sublytic unlabeled or
AF647-labeled GNLYpeptide for 20 min at 37
C, were washed with 10 mM argi-
nine in PBS for 10 min and stained with DAPI and in some cases FM4-64. Cells
were fixed with 2% formalin in PBS and imaged by confocal microscopy.
Mouse Strains
GNLY+/ BALB/c mice, originally described in Huang et al. (2007), were reder-
ived at Jackson Laboratory and backcrossed for over seven generations into
BALB/c WT mice. These were bred with Prf1/ (Jackson Laboratory) andGzmb/ BALB/c mice (kind gift of T. Ley). Experiments were performed using
6- to 9-week-old mice. Animal use was approved by the Animal Care and Use
Committees of Boston Children’s Hospital and Harvard Medical School.
Measurements of Intracellular Bacterial and Host Cell Killing
Lm-infected HeLa cells, detached by gentle trypsinization and resuspended in
10 mM HEPES, 4 mM CaCl2, 0.4% BSA in Hank’s balanced salt solution
(HBSS) at 106 cells/ml, were treated with GzmB, GNLY, and sublytic PFN (pre-
diluted in 10 mM HEPES in HBSS) at 37C. Host cell viability was assessed by
annexin V/PI staining and flow cytometry or 51Cr release assay as described
(Thiery et al., 2010). Bacterial viability was measured by colony-forming unit
(CFU) after hypotonic lysis of host cells. For some experiments, HeLa cells sta-
bly overexpressing BCL2 or empty vector were used.Cell 157, 1309–1323, June 5, 2014 ª2014 Elsevier Inc. 1321
For human CTL experiments, CD8-enriched Lm-specific T cells were added
at indicated E:T ratios and times to infected monocyte-derived dendritic cells
(MDDC). In some experiments, T cells were preincubated with 250 mM DCI or
PBS for 30min at 37Candwashedwith PBS. In some experiments, zVAD-fmk
(75 mM) or DMSO (0.75%) was added during the killing assay. For mouse T cell
experiments, Lm-infected RAW 264.7 target cells (multiplicity of infection
[MOI] = 5) were incubated for 10 min in medium containing 5 mg/ml anti-mouse
CD3ε (clone 145-2C11, eBioscience). Splenocytes, obtained from mice in-
fected with Lm 8 days earlier, were added at an E:T ratio of 3 for indicated
times. Bacterial viability was measured by CFU as above. Host cell viability
was assessed by 51Cr release assay as described (Thiery et al., 2010).
In Vivo Anti-Lm Activity
Freshly grown, exponential phase Lm (0.2 LD50) were injected intraperitoneally
(i.p.) in 0.5 ml PBS. For the primary response, liver and spleen were harvested
72 hr postinfection. For the recall response, immunemice were reinfected with
20 LD50 3 weeks later and organs were harvested after 40 hr. Organs were
weighed and homogenized in water with 0.2% Triton X-100. Colonies were
counted after plating 10-fold serial dilutions on BHI agar.
Gzm Cleavage Assays
E. coli harboring GST-fusion protein expression plasmids were induced for
15 min at 37C with 0.1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) in
LB containing 100 mg ampicillin and 2% glucose, washed and resuspended
in 20 mM NaCl, 10 mM Tris, pH 7.4 before adding Gzms and sublytic GNLY.
Reactions were stopped by boiling in SDS-PAGE loading buffer. Samples
were analyzed by immunoblot using anti-GST goat polyclonal Ab (Pharmacia).
See the Extended Experimental Procedures for detailed methods.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and six movies and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2014.03.062.
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